Kelly Ten Hagen

Kelly Ten Hagen is a renowned medical professional specializing in the field of oncology. She has made significant contributions to the understanding and treatment of various types of cancer, particularly breast cancer and lung cancer. Her research has been instrumental in the development of new chemotherapy drugs and radiation therapy techniques.

Early Life and Education

Born in Amsterdam, Netherlands, Ten Hagen showed an early interest in biology and medicine. She pursued her undergraduate studies at the University of Amsterdam, where she majored in biochemistry. She then went on to earn her medical degree from the same institution, graduating with honors.

Career

Ten Hagen began her career as a medical researcher at the Netherlands Cancer Institute. Her work focused on the development of new cancer treatments, particularly for breast cancer and lung cancer. She later moved to the United States, where she joined the National Cancer Institute as a senior researcher.

In addition to her research work, Ten Hagen has also been a prolific writer. She has authored numerous medical journals and book chapters on various aspects of oncology. Her work has been widely recognized and cited by her peers in the medical community.

Contributions to Oncology

Ten Hagen's research has led to significant advancements in the field of oncology. She has been instrumental in the development of new chemotherapy drugs that have proven to be more effective and less toxic than traditional treatments. Her work has also led to the development of new radiation therapy techniques that have improved the survival rates of cancer patients.

Awards and Recognition

In recognition of her contributions to the field of oncology, Ten Hagen has received numerous awards and honors. These include the American Cancer Society's Medal of Honor and the National Cancer Institute's Outstanding Investigator Award.